We recently compiled a list of the Top 10 Medical AI Stocks on Wall Street’s Radar. In this article, we are going to take a ...

Barclays (LON:BARC) initiated coverage on Natera shares (NASDAQ:NTRA), currently trading at $171.93, with an Overweight rating and a $200 price target. The stock has demonstrated remarkable momentum, ...

We recently compiled a list of the 10 AI News You Should Not Miss. In this article, we are going to take a look at where Arm ...

Barclays (LON:BARC) reaffirmed its positive stance on Replimune Group (NASDAQ:REPL), maintaining an Overweight rating and a $17.00 price target, representing significant upside from the current price ...

Barclays (LON:BARC) initiated coverage on Exact Sciences (NASDAQ:EXAS), a leading molecular diagnostics company with a market capitalization of $10.14 billion, assigning the stock an Overweight rating ...

We recently compiled a list of the 10 AI News You Probably Missed. In this article, we are going to take a look at where ...

Barclays (LON:BARC) adjusted the firm's stance on Netflix (NASDAQ:NFLX) stock, upgrading it from Underweight to Equalweight ...

Barclays (LON:BARC) began coverage on Guardant Health (NASDAQ:GH) shares, assigning an Overweight rating and setting a price target of $60. The new outlook comes as Guardant Health, a precision ...

Marvell Technology (NASDAQ:MRVL) and Nvidia (NASDAQ:NVDA) arise as leaders in artificial intelligence semiconductor firms in ...

The Nasdaq led gains among Wall Street's main indexes on Wednesday, as investors cheered streaming giant Netflix's strong ...

Barclays upgraded Lumentum Holdings Inc (NASDAQ:LITE) to "Overweight" from "Underweight," setting a price target of $125, ...